Cargando…

Development and validation of a questionnaire to assess delay in treatment for breast cancer

BACKGROUND: This study reports the reliability and validity of a questionnaire designed to measure the time from detection of a breast cancer to arrival at a cancer hospital, as well as the factors that are associated with delay. METHODS: The proposed questionnaire measures dates for estimation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Unger-Saldaña, Karla, Peláez-Ballestas, Ingris, Infante-Castañeda, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543238/
https://www.ncbi.nlm.nih.gov/pubmed/23272645
http://dx.doi.org/10.1186/1471-2407-12-626
_version_ 1782255622159335424
author Unger-Saldaña, Karla
Peláez-Ballestas, Ingris
Infante-Castañeda, Claudia
author_facet Unger-Saldaña, Karla
Peláez-Ballestas, Ingris
Infante-Castañeda, Claudia
author_sort Unger-Saldaña, Karla
collection PubMed
description BACKGROUND: This study reports the reliability and validity of a questionnaire designed to measure the time from detection of a breast cancer to arrival at a cancer hospital, as well as the factors that are associated with delay. METHODS: The proposed questionnaire measures dates for estimation of the patient, provider and total intervals from detection to treatment, as well as factors that could be related to delays: means of problem identification (self-discovery or screening), the patients’ initial interpretations of symptoms, patients’ perceptions of delay, reasons for delay in initial seeking of medical care, barriers perceived to have caused provider delay, prior utilisation of health services, use of alternative medicine, cancer-screening knowledge and practices, and aspects of the social network of support for medical attention. The questionnaire was assembled with consideration for previous research results from a review of the literature and qualitative interviews of patients with breast cancer symptoms. It was tested for face validity, content validity, reliability, internal consistency, convergent and divergent validity, sensitivity and specificity in a series of 4 tests with 602 patients. RESULTS: The instrument showed good face and content validity. It allowed discrimination of patients with different types and degrees of delay, had quite good reliability for the time intervals (with no significant mean differences between the two measurements), and fairly good internal consistency of the item dimensions (with Cronbach’s alpha values for each dimension between 0.42 and 0.85). Finally, sensitivity and specificity were 74.68% and 48.81%, respectively. CONCLUSIONS: To the best of our knowledge, this is the first published report of the development and validation of a questionnaire for estimation of breast cancer delay and its correlated factors. It is a valid, reliable and sensitive instrument.
format Online
Article
Text
id pubmed-3543238
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35432382013-01-14 Development and validation of a questionnaire to assess delay in treatment for breast cancer Unger-Saldaña, Karla Peláez-Ballestas, Ingris Infante-Castañeda, Claudia BMC Cancer Research Article BACKGROUND: This study reports the reliability and validity of a questionnaire designed to measure the time from detection of a breast cancer to arrival at a cancer hospital, as well as the factors that are associated with delay. METHODS: The proposed questionnaire measures dates for estimation of the patient, provider and total intervals from detection to treatment, as well as factors that could be related to delays: means of problem identification (self-discovery or screening), the patients’ initial interpretations of symptoms, patients’ perceptions of delay, reasons for delay in initial seeking of medical care, barriers perceived to have caused provider delay, prior utilisation of health services, use of alternative medicine, cancer-screening knowledge and practices, and aspects of the social network of support for medical attention. The questionnaire was assembled with consideration for previous research results from a review of the literature and qualitative interviews of patients with breast cancer symptoms. It was tested for face validity, content validity, reliability, internal consistency, convergent and divergent validity, sensitivity and specificity in a series of 4 tests with 602 patients. RESULTS: The instrument showed good face and content validity. It allowed discrimination of patients with different types and degrees of delay, had quite good reliability for the time intervals (with no significant mean differences between the two measurements), and fairly good internal consistency of the item dimensions (with Cronbach’s alpha values for each dimension between 0.42 and 0.85). Finally, sensitivity and specificity were 74.68% and 48.81%, respectively. CONCLUSIONS: To the best of our knowledge, this is the first published report of the development and validation of a questionnaire for estimation of breast cancer delay and its correlated factors. It is a valid, reliable and sensitive instrument. BioMed Central 2012-12-28 /pmc/articles/PMC3543238/ /pubmed/23272645 http://dx.doi.org/10.1186/1471-2407-12-626 Text en Copyright ©2012 Unger-Saldaña et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Unger-Saldaña, Karla
Peláez-Ballestas, Ingris
Infante-Castañeda, Claudia
Development and validation of a questionnaire to assess delay in treatment for breast cancer
title Development and validation of a questionnaire to assess delay in treatment for breast cancer
title_full Development and validation of a questionnaire to assess delay in treatment for breast cancer
title_fullStr Development and validation of a questionnaire to assess delay in treatment for breast cancer
title_full_unstemmed Development and validation of a questionnaire to assess delay in treatment for breast cancer
title_short Development and validation of a questionnaire to assess delay in treatment for breast cancer
title_sort development and validation of a questionnaire to assess delay in treatment for breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543238/
https://www.ncbi.nlm.nih.gov/pubmed/23272645
http://dx.doi.org/10.1186/1471-2407-12-626
work_keys_str_mv AT ungersaldanakarla developmentandvalidationofaquestionnairetoassessdelayintreatmentforbreastcancer
AT pelaezballestasingris developmentandvalidationofaquestionnairetoassessdelayintreatmentforbreastcancer
AT infantecastanedaclaudia developmentandvalidationofaquestionnairetoassessdelayintreatmentforbreastcancer